Showing 208 results

Filters Content type: News, Editors' picks, About HIV Topic: Treatment-experienced people

HIV treatment options for people who have a strain of HIV that is resistant to multiple drug classes.

Treatment-experienced people

WEP Clinical has partnered with TaiMed Biologics to launch a Trogarzo named patient program

Editor's pick
WEP Clinical press release
24 March 2023
Injectable & long-acting HIV treatment

Lenacapavir Shows Continued Promise for People With Drug-Resistant HIV

Editor's pick
POZ
10 November 2022
HIV treatment

IDWeek 2022 Study Bites: What’s New in HIV Antiretroviral Therapy

Editor's pick
TheBodyPro
10 November 2022
Pharmaceutical industry

Long-suffering CytoDyn withdraws HIV approval application for leronlimab, blaming clinical research organization

Editor's pick
FierceBiotech
1 November 2022
Treatment-experienced people

Lenacapavir: 75% Sub-50 Response at 52 Weeks Despite Heavy ART Experience

Editor's pick
NATAP
26 October 2022
Treatment-experienced people

FDA Approves Trogarzo for 30-Second IV Push, Simplifying HIV Treatment for Heavily Treatment-Experienced People

Editor's pick
Infectious Disease Special Edition
5 October 2022
New & experimental HIV treatments

5 FDA decisions to watch in the fourth quarter

Editor's pick
BioPharma Dive
3 October 2022
New & experimental HIV treatments

Fostemsavir Plus Optimized Background Therapy May Be Viable for Multidrug-Resistant HIV

Editor's pick
Infectious Disease Advisor
30 June 2022
Injectable & long-acting HIV treatment

Investigational Lenacapavir Receives Positive CHMP Opinion for People With Multi-Drug Resistant HIV

Editor's pick
Gilead Sciences press release
25 June 2022
Treatment-experienced people

Theratechnologies to Focus Its Commercialization Activities on the North American Territory

Editor's pick
Theratechnologies press release
28 April 2022
New & experimental HIV treatments

Top 5 HIV treatment stories from CROI 2022

News
2 March 2022
New & experimental HIV treatments

Lenacapavir shows continued promise for first-line treatment and highly resistant HIV

News
23 February 2022
Resistance

New cases of multi-drug resistant HIV becoming rarer in Europe

News
28 October 2021
HIV treatment

Etravirine (Intelence) Detailed information

About HIV
September 2021
HIV treatment

Etravirine Factsheet

About HIV
September 2021
Injectable & long-acting HIV treatment

Theratechnologies Announces Positive Results for Trogarzo® IV Push Administration Study

Editor's pick
GlobeNewswire
22 September 2021
New & experimental HIV treatments

IAS 2021: Injectable treatment for multidrug-resistant HIV Video

July 2021
New & experimental HIV treatments

Novel, twice-a-year injected drug suppresses multidrug-resistant HIV in most patients on failing therapy

News
17 July 2021
Pharmaceutical industry

Gilead files long-acting HIV med for patients running out of options

Editor's pick
FierceBiotech
1 July 2021
New & experimental HIV treatments

Gilead Submits New Drug Application to U.S. Food and Drug Administration for Lenacapavir, an Investigational, Long-Acting Capsid Inhibitor for the Treatment of HIV-1 in People With Limited Therapy Options

Editor's pick
Gilead press release
29 June 2021
HIV treatment

Fostemsavir Factsheet

About HIV
April 2021
HIV treatment

Fostemsavir (Rukobia) Detailed information

About HIV
April 2021
Treatment-experienced people

Heavily treatment-experienced people in Europe do not have a higher risk of clinical events

News
1 April 2021
New & experimental HIV treatments

HIV capsid inhibitor offers new option for people with highly resistant HIV

News
10 March 2021